← Leaderboards
Stephen E Kurtz
Oregon Health & Science University
$864,836
Attributed
$1,729,672
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $352.3K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,729,672 · 1
By mechanism
R01$1,729,672 · 1
Top collaborators
- Jeffrey Wallace Tyner5 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jeffrey Wallace Tyner$13,872,769
- Anupriya Agarwal$8,829,719
- Haijiao Zhang$1,696,427
- Bill H Chang$918,328
- Nathalie Pamir$4,494,706
Others in their field
Other Emerging Leaders on “Collection”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,108,663
- Leonard Freedman · Leidos Biomedical Research, Inc.$112,090,885
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
CollectionClustered Regularly Interspaced Short Palindromic RepeatsAzacitidineAcute Myelocytic LeukemiaAutomobile DrivingBiobankBiological MarkersBiologyAcute Myeloid Leukemia CellBiomarker ValidationBcl2 GeneCandidate Disease GeneCell Differentiation ProcessCell LineCellsChemotherapyClinicClinical BiomarkersClinical PredictorsClinical TranslationClinical Trial AnalysisClinical TrialsBlindedComplex
Grant awards (5)
Mechanisms of venetoclax combination activity in acute myeloid leukemia$352,275
R01 · FY2025 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia$334,662
R01 · FY2024 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia$345,230
R01 · FY2023 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia$345,230
R01 · FY2022 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia$352,275
R01 · FY2021 · CA